First U.S. COVID-19 shots could be given 24-to-48 hours after FDA nod - health official

FILE PHOTO: Former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who will serve as chief adviser on the effort to find a vaccine for the coronavirus disease (COVID-19) pandemic, waits to speak as President Donald Trump holds a coronavirus disease response event in the Rose Garden at the White House in Washington, U.S., May 15, 2020. REUTERS/Kevin Lamarque

(Reuters) - Healthcare workers and others recommended for the first COVID-19 inoculations could start getting shots within 24 hours after the vaccine receives regulatory authorization, the chief adviser for the U.S. government's Operation Warp Speed program said on Tuesday.

Moncef Slaoui, a former GlaxoSmithKline executive overseeing the vaccine portion of the U.S. program, said he hopes 20 million people will have been vaccinated by the end of this year.

"Within 24 hours, maybe at most 36 to 48 hours, from the approval, the vaccine can be in people's arms," Slaoui said at an event conducted by The Washington Post.

Slaoui said practice shipping runs - without vaccines - have been conducted to prepare for initial distribution expected to begin in mid-December once Pfizer Inc receives an emergency use authorization (EUA) from the U.S. Food and Drug Administration for its vaccine.

Pfizer applied for the EUA on Nov. 20 after publishing data that showed the vaccine developed with German partner BioNTech SE was 95% effective in preventing COVID-19.

A committee of outside expert advisers is scheduled to meet on Dec. 10 to discuss the data and make a recommendation to the FDA on whether to grant authorization. The agency typically follows the advice of these expert committees.

States will be in charge of distributing vaccines to their populations. Slaoui said the federal government will ship doses to the locations identified in state plans.

The United States should have 60 million to 70 million doses a month by January, between both the Pfizer and Moderna Inc vaccines, Slaoui said. Moderna's vaccine, which was about equally effective, will be reviewed by the expert panel a week after Pfizer's.

Both vaccines require patients to receive two doses about a month apart.

If experimental vaccines from Johnson & Johnson and AstraZeneca Plc also receive emergency approval, Slaoui said that will add 30 million to 50 million additional doses.

If there are four approved vaccines by early next year, manufacturing of doses should ramp up significantly in about March or April to about 150 million shots per month, he said.

J&J has said that it is on track to release an interim analysis of its large vaccine trial late this year or early next year. It would likely then need full data from the trial before applying for authorization.

Speedy U.S. clearance for the AstraZeneca vaccine appears unlikely. The company and Oxford University researchers released interim data on Nov. 23 that showed its vaccine was on average 70% effective and could be up to 90% effective against the virus with an alternate dosing regimen.

Some scientists have raised doubts about the strength of AstraZeneca's data after it turned out that patients in the UK part of the trial that showed 90% efficacy had accidentally received a half dose of the vaccine followed by the full dose.

AstraZeneca said that it will likely run an additional global trial using that dosing regimen to confirm those results.

(Reporting by Mrinalika Roy in Bengaluru and Rebecca Spalding in New York; Editing by Caroline Humer and Bill Berkrot)

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3

Did you find this article insightful?


100% readers found this article insightful

Next In World

Biden's bold immigration overhaul may face a Republican wall in Congress
Relatively spared by the coronavirus, Pakistanis drop their guard
Amazon to open pop-up COVID-19 vaccine clinic in Seattle headquarters
Alphabet shutting down Loon, which used balloon alternative to cell towers
Top Iran leader posts Trump-like golfer image, vows revenge
Japan government says no truth to report of possible Olympics cancellation
Parler faces ‘difficulties’ as Amazon wins early court fight
US charges Hambali, two Malaysians over Bali, Jakarta bombings
Japan to start coronavirus vaccinations with Pfizer vaccines
Phnom Penh yoga fans return to mat after lockdown - with a beer

Stories You'll Enjoy